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ABSTRACT 
A prospective study of 137 human immunodeficiency virus 
(HIV-infected outpatients was conducted at a New York City 
clinic to determine the seroprevalence of anticryptosporidial 
antibody, and the prevalence of cryptosporidial infection. In 
addition, the potential risk factors for cryptosporidial infection 
in an HIV-infected population in an urban environment were 
also investigated. A seroprevalence of 20.3% was found for 
anti-Cryptosporidium antibody within the urban HIV-positive 
population studied. This prevalence is within the range that has 
been established for immunocompetent populations in the 
United States and in Europe. It indicates that a significant pro- 
portion of the population has had cryptospordial infection in 
the past. Longitudinal studies are needed to establish whether 
cryptosporidiosis is a reactivation of past infection in the 
immunocompromised host. Stool samples were examined for 
ova and parasites and acid-fast stained for detection of cryp- 
tosporidial oocysts. Previously unrecognized cryptosporidial 
infection was found in 3.6% of the study population. This preva- 
lence is similiar to that reported for an HIV-infected inner city 
population in Los Angeles. The numbers obtained in this study 
may be an underestimate of the true prevalence of cryp- 
tosporidial infection, because serial stool samples were not 
examined and because there is evidence that the commonly 
used acid-fast method for identification of Cryptosporidium in 
stool is insensitive. There was no correlation between risk fac- 
tors for cryptosporidial infection and either stool or seropositivity. 
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Cryptosporidium is an intestinal protozoan parasite that 
causes profuse, watery diarrhea in the infected human 
host. Severity of disease varies with host immune com- 
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petence. In immunocompetent hosts, cryptosporidiosis 
is a self-limited illness, usually lasting 10 to 14 days with- 
out treatment. In immunocompromised individuals, cryp- 
tosporidial infection is characterized by debilitating, 
chronic, often cholera-like diarrhea with associated severe 
abdominal pain, loss of more than 10% of body weight, 
and dehydration.‘-* Over the past decade, as the human 
immunodeficiency virus (HIV) pandemic has generated 
staggering numbers of immunocompromised individuals 
worldwide, increasing attention has been paid to CY~$- 
tosporidium as a significant human pathogen and an 
important public health concern. 
Cryptosporidial infection contributes significantly to 
the morbidity and mortality of HIV disease.There is no 
proven consistently effective therapy for cryptosporidial 
infection at the present time although paromomycin is 
widely used, and promising results have been achieved 
with azithromycin and nitazoxanide.5 
Transmission of Cryptosporidium is known to occur 
from animals to humans, from humans to humans, and via 
ingestion of contaminated water and food.6-10 The Mil- 
waukee outbreak of 1993 in which over 400,000 people 
were infected with Cryptosporidium after drinking con- 
taminated municipal water heightened awareness of the 
potential for waterborne transmission of this parasite.“-I3 
The epidemiology of cryptosporidiosis in the HIV- 
infected individual has not been well studied.‘*-‘* Two 
large-scale studies of prevalence have focused on homo- 
sexual men and patients with AIDS. **~j The prevalence of 
cryptosporidial infection in all subjects at risk for HIV 
and at all stages of the infection has not been character- 
ized. Although it is known that transmission of this par- 
asite to humans occurs via fecal-oral contamination, the 
relative importance of different risk factors, particularly 
for HIV-infected persons in different risk groups has not 
been defined. Whether cryptosporidiosis in the HIV- 
infected patient reflects de novo infection or reactiva- 
tion of previously acquired infection also is not known. 
The goals of this study were to define the prevalence 
of cryptosporidial infection as determined by finding 
Cryptosporidium oocysts in a stool sample and the preva- 
lence of positive anti-cryptosporidial serology in an HIV- 
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positive population, including all risk groups and all stages 
of HIV disease. In addition, an attempt was made to begin 
to investigate potential risk factors for cryptosporidial 
infection in an urban environment. 
METHODS 
Study Population 
The study was conducted at the Center for Special Stud- 
ies, an outpatient HIV clinic at the New York Hospital- 
Cornell Medical Center in New York City. This was a 
prospective study in which patients were recruited 
sequentially as they came into the clinic for routine 
appointments over a 6-week period in July and August 
of 1990. Participants were enrolled in the study without 
regard to gender, HIV infection risk factor, stage of HIV 
disease, or presence of gastrointestinal symptoms. Only 
those individuals with a known history of cryptosporidial 
infection were excluded from the study. 
Serology 
Blood for serum analysis (3-7 mL) was obtained from 
study participants at the same time that blood was drawn 
for routine clinic studies. Sera were examined for anti- 
cryptosporidial immunoglobulin G (IgG), using an 
enzyme-linked immunosorbent assay (ELISA) technique, l9 
in the laboratory of one of the investigators (RS). 
Stool Examination 
Participants were given specimen cups and asked to pro- 
vide a fresh stool sample. Most patients waited until their 
next clinic appointment to do so. These patients were 
instructed to bring in a sample from their morning bowel 
movement on the day of their next appointment. If this 
was not possible, they were told to refrigerate a specimen 
from the previous evening. One stool sample from each 
subject who participated in this part of the study was 
examined for Cryptosporidium oocysts in the Clinical 
Parasitology Laboratory of The New York Hospital, using 
a modified acid-fast method.*O Samples also were screened 
for other ova and parasites as per the laboratory routine. 
All samples were concentrated by centrifugation. 
Exposure Data 
An extensive questionnaire was administered to all sub- 
jects by the same investigator (KLS) at the time of entry 
into the study. Information was obtained on a variety of 
potential risk factors for cryptosporidial infection, includ- 
ing, but not limited to: travel, contact with animals, chil- 
dren, friends, or family experiencing diarrhea, and the 
primary source of drinking water. 
Clinical Data 
Risk factors for HIV infection, Centers for Disease Con- 
trol and Prevention (CDC)-defined stage of HIV illness,” 
and CD4 counts at the time of study entry were obtained 
for all patients by chart review. 
Statistics 
Statistical analysis of the data was performed using Epi 
Info (Centers for Disease Control [CDC], Atlanta, GA). 
Statistical significance was established using &i-square 
and Fisher’s exact test. 
RESULTS 
Of the 137 subjects enrolled in the study, 87 (64%) sub- 
mitted stool samples, 123 (90%) gave a blood sample, and 
the questionnaire was administered to 61 (45%) subjects. 
Fifty-nine (43%) subjects provided all three. 
The demographics of the study population, including 
gender, HIV infection risk factor, and the stage of HIV dis- 
ease (CDC-defined) at the time of entry into the study are 
presented in Table 1 .The mean age of the study popula- 
tion was 37.4 years (range: 23-65 yr).The distribution of 
CD4 counts for the entire study population, by HIV risk 
factor, is shown in Table 2. 
Parasites were detected in 10 (12%) of the 87 stool 
specimens submitted for ova and parasite examination 
(Table 3). Cryptosporidium oocysts alone were detected 
in 3 (3.6%) of the 10 specimens found to have parasites. 
Three of the 10 subjects with positive stool examinations 
were co-infected with two organisms. 
The three subjects infected with Cryptosporidium 
included a homosexual man with acquired immunodefi- 
ciency syndrome (AIDS) and a CD4 count of 100 (stage 
Table 1. Study Population Demographics of 137 Subjects: 
Gender, HIV Risk Factor, and Clinical Stage of HIV Disease at the 
Time of Entry into the Study 
H/V Disease Stage* 
(n !39) (n f37) (n z67) 
Female (n = 31) (23%) 14 8 9 
Male (n = 106) (77%) 25 23 58 
Gay/bisexual (n = 59) (43%) 6 12 41 
Intravenous drug user (n = 45) (33%) 22 10 13 
Heterosexual+ (n = 20) (15%) 8 6 6 
Transfusion (n = 9) (7%) 2 2 5 
Gay + intravenous drug user (n = 3) (2%) 1 0 2 
Heterosexual + intravenous 
drug user (n = 1) (<I %) 0 1 0 
*CDC Classification System.” 
+Female heterosexual contact of HIV-infected male. 
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Table 2. Distribution of CD4 Count and HIV Risk Factor at the Table 3. Parasitic Organisms Detected in the Stool Specimens of 
Time of Entry into the Study 87 Subjects Who Provided Samples 
CD 4 Count >500 2OC-500 <200 
n = 76 (72%) n = 34 (25%) n = 86 (63%) 
Gay/bisexual (n = 58) 2 11 45 
Intravenous drug user 
(n = 45) 8 20 17 
Heterosexual+ (n = 20) 5 2 13 
Transfusion (n = 9) 1 0 8 
Gay + intravenous 
drug user (n = 3) 0 1 2 
Heterosexual + intravenous 
drug user (n = 1) 0 0 1 
*CD4 count not available for one patient. 
+Female heterosexual contact of HIV-infected male 
C3), and two asymptomatic (stage A3) women with CD4 
counts of 102 and 20, respectively. One of the infected 
women was an intravenous drug user; the other was the 
sexual partner of an HIV-infected man.The man and one 
of the women were experiencing diarrhea at the time of 
study entry Cryptosporidiosis was the AIDS-defining diag- 
nosis for both women. Cvyptosporidium represented over 
one third of all enteric pathogens isolated in this study, 
and the prevalence of previously undiagnosed Cryp- 
tosporidium infection was 3.6% in the study population. 
Two patients were excluded from the study because they 
had been diagnosed with cryptosporidial infection prior 
to study entry. 
Serum from 123 subjects was analyzed for IgG anti- 
body to Cryptosporidium.Twenty-five (20.3%) of the 123 
subjects had positive titers (5 were females, 25 were 
males). No statistically significant correlation was found 
between the subset of the study population with anticryp- 
tosporidial IgG and gender, HIV infection risk factors, 
stage of HIV disease, CD4 count, or risk factors for cryp- 
tosporidiosis. The distribution of CD4 counts and risk 
factors for HIV infection among subjects with anticryp- 
tosporidial IgG is shown inTable 4. Of the three subjects 
with Cryptosporidium-positive stool, neither woman was 
found to have anticryptosporidial antibody and serum 
was not obtained from the man.The sensitivity and speci- 
ficity of the ELISA used to detect anticryptosporidial 
immunoglobulin G is 95%.19 
Statistical analysis of the potential risk factors for 
cryptosporidial infection, including travel; contact with 
children, friends, or family with diarrhea1 illness; contact 
with animals; or the source of drinking water yielded no 
association with either a positive serology or a positive 
stool examination, but this may have been due to the 
small sample size. 
DISCUSSION 
The serologic analysis performed for this study indicates 
that there is a seroprevalence of at least 20.3% for IgG to 
Organism Number of Specimens (n = 10) 
Cryptosporidium 3 (3.6%) 
Giardia lamb//a 1 
Giardia lamblia + Blastocystis hominis 1 
Entamoeba histolytica + Entamoeba nana 1 
Escherichia co/i + Entamoeba nana 1 
Entamoeba nana 1 
Blastocystis hominis 2 
Cryptosporidium in HIV-infected persons.This study did 
not include persons with previously diagnosed cryp- 
tosporidiosis, and thus, the rate of seroprevalence 
obtained may be an underestimate of the true sero- 
prevalence for the HIV-positive population. This study 
does not support the common assumption that homo- 
sexual men are at increased risk for cryptosporidial infec- 
tion. The data reported here indicate that there is no 
increased association between prevalence of IgG anti- 
body to Cryptosporidium and any one particular HIV 
risk group. Approximately 20% of all HIV-positive indi- 
viduals from each risk group evaluated had a previous 
exposure to Cryptosporidium as determined by pres- 
ence in serum of IgG antibody to Cryptosporidium.This 
prevalence of positive anti-Cvptosporidium IgG is within 
the range established for immunocompetent populations 
in other studies.22,23 
The significance of positive IgG anti-cryptosporid- 
ium antibody titers and whether they offer some pro- 
tection against disease is unclear. Of the two patients 
Table 4. Presence of Anti-Ctypfosporidium Antibody as a 
Function of CD4 Count and HIV Risk Factor 
Number of Subjects* 
IgG Positive n (%) IgG Negative n (%) 
CD4 Count 
<200 16 (21) 62 (79) 
200-500 7 (23) 23 (77) 
>500 2 (13) 13 (87) 
Risk Factor for HIV 
Gay/bisexual 10 (19) 43 (81) 
Intravenous drug user 8 (20) 32 (80) 
Heterosexual 3 (18) 14 (82) 
Transfusion 3 (33) 6 (67) 
Gay + intravenous drug user 1 (33) 2 (67) 
Heterosexual + intravenous 
drug user 0 1 
*Percent of subjects with given CD4 count and positive IgG. 
P-value was not significant for any category of CD4 count or risk factor. 
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with cryptosporidial infection who were tested for anti- 
body, neither was found to have detectable titersThis is 
consistent with the known inability of late-stage AIDS 
patients to generate an appropriate humoral response to 
antigens with which they are infected. Longitudinal stud- 
ies will be required to establish the role of antibody in 
the pathogenesis of cryptosporidiosis. 
A prevalence of 3.6% for previously unrecognized 
cryptosporidial infection was demonstrated in the study 
population by analysis of stool specimens.This is similar 
to the 6% prevalence that has been reported for HIV- 
infected attendees at an inner city clinic in Los Angeles. l7 
The prevalence in the present study population is much 
lower, however, than the 15 to 16% prevalence rate 
reported in homosexual men with AIDS and diarrhea. 14,1i 
This might be explained by the fact that this study pop- 
ulation included all HIV-infected individuals irrespective 
of their risk factor for HIV infection, and the presence of 
gastrointestinal symptoms. Thus, the prevalence of cryp- 
tosporidial infection obtained in this small study (3.6%) 
represents an estimate of the prevalence of cryp- 
tosporidiosis within the context of the broad spectrum 
of HIV disease. 
The prevalence of cryptosporidial infection in this 
study population may in fact be an underestimate of the 
true prevalence for a number of reasons. Instead of the 
conventional three specimens that are obtained for ova 
and parasite screening, single stool samples were exam- 
ined from the study population. In addition, the sensitiv- 
ity of the acid-fast staining method currently used to 
identify Cfyptosporidium oocysts has been shown to be 
low in recently reported seeding studies.24 
The data obtained from this study are consistent with 
published reports of asymptomatic carriage of Cryp- 
tosporidium in stool and duodenal aspirates.25-27 These 
data suggest that cryptosporidiosis may be a reactivated 
disease in the immunocompromised host. If cryp- 
tosporidial infection in AIDS patients reflects the reacti- 
vation of old disease rather than infection acquired de 
novo, then efforts should be aimed at developing effec- 
tive prophylactic regimens. If the disease is primarily due 
to newly acquired infection, delineation of risk factors 
and successful modes of prevention need to be empha- 
sized.This study characterizes a cohort of patients at one 
point in time. A longitudinal study in which stool samples, 
serum serology, and clinical symptoms are followed over 
time may help elucidate the natural history of cryp- 
tosporidiosis in the immunocompromised host. 
It is important to recognize that HIV-infected indi- 
viduals without diarrhea may be shedding infectious 
Cryptosporidium oocysts. In an urban environment 
where family members may be sharing close quarters 
and where there may be multiple HIV-infected individu- 
als in one household, these situations should be identified, 
and the appropriate precautions should be recommended 
to prevent the spread of this potentially devastating 
infection. 
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